Tests exercises and desensitization for balance and fear of falling after stroke
Tests Otago exercises and desensitization with physical therapy in older adults after stroke.
Plain-language title generated from the registry record
Registry title: Effects of Otago Exercises and Systematic Desensitization on Balance,Fall Risk and Basophobia Among Post Stroke Patients
Key facts
- Where
- Sialkot, PakistanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 70 years old?
Source: NCT07063368, who can take part
Where in Pakistan
- Allama Iqbal Memorial Teaching HospiatlSialkot, PakistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Riphah International University
- Trial code
- NCT07063368
- Record updated
- 14 July 2025
- Original description
The aim of the study is to determine the combined effects of Otago exercises and systematic desensitization on balance, fall risk, and basophobia among post-stroke older adults.Read full original descriptionShow less
Combined Effects of Otago Exercises and Systematic Desensitization on Balance,Fall Risk and Basophobia Among Post Stroke Older Adults
The aim of the study is to determine the combined effects of Otago exercises and systematic desensitization on balance, fall risk, and basophobia among post-stroke older adults.
Inclusion: Both male and female patients; 40 to 70 Years of age; sub-acute ischemic stroke; Ability to walk with or without a caregiver; No cognitive dysfunction that would hinder understanding of the instructions; MoCA score between 18-24.
Exclusion: Patients previous participation in studies similar to the present study; Participants who have other medical conditions such as severe arthritis or joint injuries; Participants who have a history of significant neurological or psychiatric disorders; Participants who have severe visual or hearing impairments; Participants who are currently participating in another clinical trial or research study.